STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on May 5, 2025

Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros

Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros

Le financement intervient à la suite de la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et à la suite de l’atteinte d’autres conditions préalables.  Daix (France), New York City (New York …

IT News Africa and Infobip Host Webinar to Revolutionize Digital Debt Recovery for BFSI

IT News Africa and Infobip Host Webinar to Revolutionize Digital Debt Recovery for BFSI

JOHANNESBURG, May 05, 2025 (GLOBE NEWSWIRE) -- As Africa’s BFSI sector navigates a rapidly growing lending market, digital debt recovery has become critical for success. Artificial Intelligence (AI) is reshaping this landscape, enabling financial …

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer

Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall Survival of 23 months from date of diagnosis [95% CI; 17 …

NANOBIOTIX PRÉSENTE LES RÉSULTATS COMPLETS DE L’ÉTUDE DE PHASE 1 ÉVALUANT JNJ-1900 (NBTXR3) DANS LE CANCER DU PANCREAS

NANOBIOTIX PRÉSENTE LES RÉSULTATS COMPLETS DE L’ÉTUDE DE PHASE 1 ÉVALUANT JNJ-1900 (NBTXR3) DANS LE CANCER DU PANCREAS

Les résultats ont démontré un bon profil de tolérance, une faisabilité d’injection satisfaisante, ainsi que des signaux cliniques encourageants en matière d‘activité antitumorale chez des patients atteints d’un cancer du pancréas localement avancé ou à la …

SAGA Metals Reports Significant Drill Results from Maiden Drill Program at Radar Ti-V-Fe Project in Labrador

SAGA Metals Reports Significant Drill Results from Maiden Drill Program at Radar Ti-V-Fe Project in Labrador

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discovery, is pleased to announce drill …

Dr. Jacob Buinewicz Achieves Double Board Certification

Dr. Jacob Buinewicz Achieves Double Board Certification

DOYLESTOWN, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Just in time for Mental Health Awareness Month in May, Dr. Jacob Buinewicz is proud to announce that he has achieved a second board certification from the American Board of Psychiatry and Neurology. Dr. …

GENFIT to Present Latest ACLF Research at EASL Congress 2025

GENFIT to Present Latest ACLF Research at EASL Congress 2025

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025

GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 5 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, 2025 – Roquette, a global leader in plant-based …

Roquette présente une nouvelle organisation à la suite de l’acquisition  d’IFF Pharma Solutions

Roquette présente une nouvelle organisation à la suite de l’acquisition d’IFF Pharma Solutions

Roquette présente une nouvelle organisation à la suite de l’acquisition d’IFF Pharma Solutions L’entreprise se structure avec deux Business Groups repensés et renforcés, et nomme leurs nouveaux dirigeants Lille, le 5 mai 2025 – Roquette, un leader mondial …

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today a co-discovery alliance …

Movellus 推出业内首款片上电源传输网络分析仪

Movellus 推出业内首款片上电源传输网络分析仪

圣克拉拉,加利福尼亚州, May 05, 2025 (GLOBE NEWSWIRE) -- Movellus 今天宣布推出业内首款用于电源传输网络 (PDN) 表征与监控的片上传感器。电源完整性对任何片上系统 (SoC) 的性能和效率都至关重要。然而,业界对片上 PDN 性能的了解非常有限,这可能会导致电压设置过高(从而影响功耗和性能)、未能达到性能目标和更高的不良率 (DPPM)。随着行业向更大的 SoC、堆叠芯片和芯粒发展,这个问题会变得更加突出,使得对 PDN …

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives,  Strategic Corporate Developments, and Potential Opportunities for  Expansion into Southeast Asia

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service